Life Sciences: Accelerating innovation, personalised healthcare and the pandemic impact

On the Bid is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week.

In this edition, host Oriel Morrison discusses innovations in the life sciences sector. Specifically, the rapid rate of growth for innovation we have witnessed during this global pandemic. As well as the increased interest in personalised healthcare and custom medicines and opportunities and strategies for investors in the life science sector.

On the expert panel this week is Glenn Cross, chairman of EZZ Life Science (ASX:EZZ) and Matt McNamara, chief investment officer at Horizon 3 Biotech.

Glenn Cross has over 40 years experience in the life sciences sector and has held senior executive roles in both multinational and Australian companies.

Matt McNamara has over 30 years experience in the healthcare and medical sciences sector, with more than 20 years as a venture capitalist.

So click above to tune in!